OIERX | VIVAX | OIERX / VIVAX | |
Total Expense Ratio | 0.55 | 0.17 | 324% |
Annual Report Gross Expense Ratio | 0.55 | 0.17 | 324% |
Fund Existence | 15 years | 33 years | - |
Gain YTD | 11.116 | 9.404 | 118% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 3000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 44B | 203B | 22% |
Annual Yield % from dividends | 1.68 | 1.99 | 84% |
Returns for 1 year | 4.44 | 7.55 | 59% |
Returns for 3 years | 25.46 | 38.11 | 67% |
Returns for 5 years | 60.26 | 74.26 | 81% |
Returns for 10 years | 132.54 | 137.69 | 96% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
GNOM | 37.94 | 1.18 | +3.22% |
Global X Genomics & Biotechnology ETF | |||
VBR | 211.71 | 2.71 | +1.30% |
Vanguard Small-Cap Value ETF | |||
EOI | 21.09 | N/A | N/A |
Eaton Vance Enhanced Equity Income Fund | |||
JLQD | 42.37 | N/A | N/A |
Janus Henderson Corporate Bond ETF | |||
OPP | 8.59 | -0.02 | -0.23% |
RiverNorth/DoubleLine Strategic Opportunity Fund |